NeoGenomics amends CEO employment agreement with $3.35M restricted stock inducement and $800K relocation

NEOGENOMICS INC

Amendment provides incoming CEO Christopher Smith restricted stock inducement with target value of approximately $3,350,000.
Additional relocation benefits of $800,000 are included in the amendment.
Amendment effective August 15, 2022; all other terms of original employment agreement unchanged.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.